SNP Genetics Inc. announced a private placement of 411,184 shares at a price of KRW 6,080 per share for gross proceeds of KRW 2,499,998,720 on April 6, 2022. The company announced that it has received funding trough third party allotment of capital. The transaction has been approved by board of directors of the company and is expected to close on April 14, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,400 KRW | +0.80% | -2.11% | -33.03% |
1st Jan change | Capi. | |
---|---|---|
-33.03% | 9.56M | |
-31.90% | 9.3B | |
-6.25% | 3.1B | |
+25.95% | 2.87B | |
-13.96% | 2.17B | |
-16.83% | 1.75B | |
+72.82% | 1.5B | |
+29.17% | 807M | |
-2.62% | 759M | |
-26.33% | 532M |
- Stock Market
- Equities
- A086460 Stock
- News Curable. Inc.
- SNP Genetics Inc. announced that it expects to receive KRW 2.49999872 billion in funding